SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
Today 4:03 PM View: | Inhibrx Biosciences, Inc. (INBX) | 20-Nov-24 | Purchase | 37,500 | $14.19 | $532,204.00 | 37% 102.19K to 139.69K | |
Today 4:03 PM View: | Inhibrx Biosciences, Inc. (INBX) | 19-Nov-24 | Purchase | 69,686 | $14.23 | $991,416.00 | 214% 32.5K to 102.19K | |
24-Jun-24 5:27 PM View: | Inhibrx Biosciences, Inc. (INBX) | 24-Jun-24 | Gift | 20,000 | -- | -- | 2% 1.16M to 1.18M | |
24-Jun-24 5:27 PM View: | Inhibrx Biosciences, Inc. (INBX) | 24-Jun-24 | Gift | 89,050 | -- | -- | (8%) 1.18M to 1.09M | |
07-Jun-24 6:05 PM View: | Inhibrx Biosciences, Inc. (INBX) | 05-Jun-24 | Purchase | 57,549 | $17.32 | $997,024.00 | 5% 1.09M to 1.15M | |
04-Jun-24 5:27 PM View: | Inhibrx Biosciences, Inc. (INBX) | 04-Jun-24 | Purchase | 89,063 | $17.65 | $1,572,240.00 | 9% 1.0M to 1.09M | |
04-Jun-24 5:27 PM View: | Inhibrx Biosciences, Inc. (INBX) | 03-Jun-24 | Purchase | 127,530 | $17.43 | $2,222,430.00 | 15% 876.27K to 1.0M | |
04-Jun-24 5:27 PM View: | Inhibrx Biosciences, Inc. (INBX) | 31-May-24 | Purchase | 70,193 | $16.14 | $1,132,920.00 | 9% 806.08K to 876.27K | |
30-May-24 6:22 PM View: | Inhibrx, Inc. (INBX) | 30-May-24 | Disposition | 3,274,300 | $30.00 | $98,229,000.00 | (100%) 3.27M to 0 | |
30-May-24 6:10 PM View: | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Grant | 818,575 | -- | -- | 100% 0 to 818.58K | |
07-Aug-23 5:30 PM View: | Biodesix Inc (BDSX) | 03-Aug-23 | Grant Duplicate | 6,172 | $1.62 | $9,998.64 | 2% 351.37K to 357.54K | |
04-Apr-23 4:36 PM View: | Biodesix Inc (BDSX) | 31-Mar-23 | Option Exercise | 145,833 | -- | -- | 71% 205.53K to 351.37K | |
23-Jan-23 6:10 PM View: | Inhibrx, Inc. (INBX) | 23-Jan-23 | Sale (Planned) | 9,500 | $25.26 | $239,999.00 | (< 1%) 3.28M to 3.27M | |
22-Dec-22 4:31 PM View: | Biodesix Inc (BDSX) | 21-Dec-22 | Option Exercise | 31,619 | -- | -- | 18% 173.91K to 205.53K | |
22-Dec-22 4:04 PM View: | Inhibrx, Inc. (INBX) | 21-Dec-22 | Sale (Planned) | 9,500 | $27.02 | $256,679.00 | (< 1%) 3.29M to 3.28M | |
21-Nov-22 6:02 PM View: | Biodesix Inc (BDSX) | 21-Nov-22 | Private Purchase | 173,913 | $1.15 | $200,000.00 | 100% 0 to 173.91K | |
22-Nov-22 4:42 PM View: | Inhibrx, Inc. (INBX) | 21-Nov-22 | Sale (Planned) | 9,500 | $29.89 | $283,972.00 | (< 1%) 3.3M to 3.29M | |
24-Oct-22 4:36 PM View: | Inhibrx, Inc. (INBX) | 21-Oct-22 | Sale (Planned) | 9,500 | $30.13 | $286,232.00 | (< 1%) 3.31M to 3.3M | |
25-Aug-22 4:20 PM View: | Inhibrx, Inc. (INBX) | 24-Aug-22 | Gift | 11,900 | -- | -- | (< 1%) 3.32M to 3.31M | |
08-Aug-22 4:22 PM View: | Inhibrx, Inc. (INBX) | 05-Aug-22 | Gift | 3,400 | -- | -- | (< 1%) 3.33M to 3.32M | |
02-Aug-22 4:52 PM View: | Inhibrx, Inc. (INBX) | 02-Aug-22 | Gift | 50,000 | -- | -- | 1% 3.4M to 3.45M | |
02-Aug-22 4:52 PM View: | Inhibrx, Inc. (INBX) | 02-Aug-22 | Gift | 118,500 | -- | -- | (3%) 3.45M to 3.33M | |
06-Feb-18 8:24 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Feb-18 | Market Sale | 148 | $5.13 | $759.24 | (< 1%) 911.66K to 911.51K | (23%) |
06-Dec-17 6:20 PM View: | GenMark Diagnostics, Inc. (GNMK) | 04-Dec-17 | Market Sale | 135 | $4.70 | $634.50 | (< 1%) 911.8K to 911.66K | (34%) |
21-Nov-17 6:04 PM View: | GenMark Diagnostics, Inc. (GNMK) | 20-Nov-17 | Market Sale | 1,269 | $4.74 | $6,015.06 | (< 1%) 913.07K to 911.8K | (33%) |
03-Nov-17 7:50 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Nov-17 | Market Sale | 135 | $7.24 | $977.40 | (< 1%) 913.2K to 913.07K | 13% |
06-Sep-17 6:08 PM View: | GenMark Diagnostics, Inc. (GNMK) | 05-Sep-17 | Market Sale | 133 | $9.75 | $1,296.75 | (< 1%) 913.34K to 913.2K | 35% |
23-Aug-17 2:36 PM View: | GenMark Diagnostics, Inc. (GNMK) | 21-Aug-17 | Market Sale | 1,277 | $9.45 | $12,067.60 | (< 1%) 914.61K to 913.34K | 33% |
04-Aug-17 1:25 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Aug-17 | Market Sale | 138 | $10.33 | $1,425.54 | (< 1%) 914.75K to 914.61K | 39% |
05-Jun-17 4:58 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Jun-17 | Market Sale | 132 | $12.89 | $1,701.48 | (< 1%) 914.88K to 914.75K | 51% |
23-May-17 4:52 PM View: | GenMark Diagnostics, Inc. (GNMK) | 19-May-17 | Market Sale | 1,265 | $12.89 | $16,305.90 | (< 1%) 916.15K to 914.88K | 51% |
04-May-17 5:10 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-May-17 | Market Sale | 133 | $13.34 | $1,774.22 | (< 1%) 916.28K to 916.15K | 53% |
09-Mar-17 7:53 PM View: | GenMark Diagnostics, Inc. (GNMK) | 07-Mar-17 | Market Sale | 311 | $12.18 | $3,787.98 | (< 1%) 916.59K to 916.28K | 48% |
03-Mar-17 7:13 PM View: | GenMark Diagnostics, Inc. (GNMK) | 03-Mar-17 | Market Sale | 131 | $12.29 | $1,609.99 | (< 1%) 916.72K to 916.59K | 49% |
24-Feb-17 7:19 PM View: | GenMark Diagnostics, Inc. (GNMK) | 22-Feb-17 | Grant | 48,750 | -- | -- | 6% 867.97K to 916.72K | |
21-Feb-17 8:02 PM View: | GenMark Diagnostics, Inc. (GNMK) | 21-Feb-17 | Market Sale | 5,250 | $10.08 | $52,920.00 | (< 1%) 873.22K to 867.97K | 37% |
03-Feb-17 5:46 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Feb-17 | Market Sale | 131 | $11.58 | $1,516.98 | (< 1%) 873.35K to 873.22K | 46% |
20-Jan-17 6:49 PM View: | GenMark Diagnostics, Inc. (GNMK) | 19-Jan-17 | Option Exercise | 13,631 | -- | -- | 2% 865.44K to 879.07K | |
20-Jan-17 6:49 PM View: | GenMark Diagnostics, Inc. (GNMK) | 19-Jan-17 | Market Option Sale | 5,718 | $12.47 | $71,303.50 | (< 1%) 879.07K to 873.35K | 49% |
09-Dec-16 5:59 PM View: | GenMark Diagnostics, Inc. (GNMK) | 07-Dec-16 | Market Sale | 313 | $11.08 | $3,468.04 | (< 1%) 865.75K to 865.44K | 43% |
06-Dec-16 5:58 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Dec-16 | Market Sale | 132 | $11.30 | $1,491.60 | (< 1%) 865.88K to 865.75K | 44% |
04-Nov-16 5:37 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Nov-16 | Market Sale | 135 | $10.30 | $1,390.50 | (< 1%) 866.02K to 865.88K | 39% |
09-Sep-16 6:36 PM View: | GenMark Diagnostics, Inc. (GNMK) | 07-Sep-16 | Market Sale | 310 | $8.69 | $2,693.90 | (< 1%) 866.33K to 866.02K | 27% |
06-Sep-16 6:02 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Sep-16 | Market Sale | 133 | $8.62 | $1,146.46 | (< 1%) 866.46K to 866.33K | 27% |
04-Aug-16 5:21 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Aug-16 | Market Sale | 135 | $9.88 | $1,333.80 | (< 1%) 866.6K to 866.46K | 36% |
07-Jun-16 7:20 PM View: | GenMark Diagnostics, Inc. (GNMK) | 07-Jun-16 | Market Sale | 310 | $8.98 | $2,783.80 | (< 1%) 866.91K to 866.6K | 30% |
07-Jun-16 7:20 PM View: | GenMark Diagnostics, Inc. (GNMK) | 03-Jun-16 | Market Sale | 125 | $8.53 | $1,066.25 | (< 1%) 867.03K to 866.91K | 26% |
04-May-16 5:27 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-May-16 | Market Sale | 135 | $5.79 | $781.65 | (< 1%) 867.17K to 867.03K | (9%) |
09-Mar-16 5:07 PM View: | GenMark Diagnostics, Inc. (GNMK) | 07-Mar-16 | Market Sale | 364 | $5.76 | $2,096.64 | (< 1%) 867.53K to 867.17K | (10%) |
03-Mar-16 5:52 PM View: | GenMark Diagnostics, Inc. (GNMK) | 02-Mar-16 | Market Sale | 157 | $4.87 | $764.59 | (< 1%) 867.69K to 867.53K | (30%) |